Skip to main content
SpringerLink
Log in

Atrial natriuretic peptide and arginine-vasopressin secretion in patients with active renal stone disease

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

The pathogenesis of active renal stone disease (ARSD) is still not fully elucidated. In the present study the role of atrial natriuretic peptide (ANP) and arginine-vasopressin (AVP) as potential pathogenetic factors in ARSD were examined. Thirty patients with ARSD and 21 healthy subjects (HS) were examined both under bed rest (BR) and head-out water immersion (WI) conditions. Serum concentrations of electrolytes (Na, Ca, Mg), ANP and AVP were assessed before (0′), and after 60 and 120 minutes of BR or WI, respectively. Urinary excretions of Na, Ca, Mg, and oxalates were also estimated during BR and WI.

Patients with ARSD showed higher basal plasma levels of ANP and a greater response of ANP secretion, but a lower suppression of plasma AVP to WI induced hypervolaemia as compared with the controls. In addition, in patients with ARSD the physiological relationship between plasma AVP concentration and urinary excretion of Ca and Mg (positive correlation), between plasma ANP level and urinary excretion of Ca and Mg (negative correlation), and between plasma ANP and AVP concentration (negative correlation), respectively, were absent. In addition, patients with ARSD showed a positive correlation between plasma ANP and urinary oxalate excretion. From the results obtained in this study we conclude that both AVP and ANP may be involved in the pathogenesis of ARSD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anand-Srivastava, M. B., Cantin, M., Genest, I.: Inhibition of pituitary adenylate cyclase by atrial natriuretic factor.Life Sci., 36, 1873 (1985).

    Article  PubMed  CAS  Google Scholar 

  2. Anderson, J. V., Donckier, J., Payne, N. N., Beacham, J., Slater, J. D., Bloom, S. R.: Atrial natriuretic peptide: Evidence of action as a natriuretic hormone at physiological plasma concentrations in man.Clin. Sci., 72, 305 (1987).

    PubMed  CAS  Google Scholar 

  3. Biollaz, J., Nussberger, J., Porchet, M., Brunner-Ferber, F., Otterbein, E. S., Gomez, H., Waeber, B., Brunner, H. R.: Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.Hypertension, 8, Suppl. 2, II96 (1986).

    PubMed  CAS  Google Scholar 

  4. Broadus, A. E., Horst, R. L., Lang, L., Liftledike, E. T., Rasmussen, H.: The importance of circulating 1,25 dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.N. Engl. J. Med., 302, 421 (1980).

    Article  PubMed  CAS  Google Scholar 

  5. Coe, F. L., Parks, J. H., Asplin, J. R.: The pathogenesis and treatment of kidney stones.N. Engl. J. Med., 327, 1141 (1992).

    Article  PubMed  CAS  Google Scholar 

  6. Dillingham, M. A., Anderson, R. J.: Inhibition of vasopressin action by atrial natriuretic factor.Science, 231, 1572 (1986).

    Article  PubMed  CAS  Google Scholar 

  7. Fujio, M., Ohasi, M., Nawata, M., Kato, K., Ibayashi, H., Kangawa, K., Matsuo, H.: Alpha-human atrial natriuretic polypeptide reduces the plasma arginine vasopressin concentration in human subjects.Clin. Endocrinol., 25, 181 (1986).

    CAS  Google Scholar 

  8. Gerbes, A. L., Vollmar, A. M.: Degradation and clearance of atrial natriuretic factors (ANF).Life Sci., 47, 1173 (1990).

    Article  PubMed  CAS  Google Scholar 

  9. Greenleaf, J. E., Shvartz, E., Keil, L. C.: Hemodilution, vasopressin suppression, and diuresis during water immersion in man.Aviat. Space Environ. Med., 52, 329 (1981).

    PubMed  CAS  Google Scholar 

  10. Kiersztejn, M., Kuczera, M., Kokot, F.: Verhalten der Prolaktinsekretion und des 25-Hydroxy-cholecalciferolspiegels bei Kranken mit aktiver Nierensteinkrankheit.Z. Urol. Nephrol., 81, 431 (1988).

    PubMed  CAS  Google Scholar 

  11. Kokot, F., Grzeszczak, W., Więcek, A.: Water immersion induced alterations of atrial natriuretic factor in patients with noninflammatory acute renal failure.Nephrol. Dial. Transplant., 4, 691 (1989).

    PubMed  CAS  Google Scholar 

  12. Kokot, F., Kokot, S.: Renal stone disease—pathogenesis and therapy (in Polish).Przegl. Lek., 45, 469 (1988).

    PubMed  CAS  Google Scholar 

  13. Kokot, F., Stupnicki, R.: Radioimmunological and radiocompetitive methods used in the clinical practice (in Polish), National Medical Publisher Institute, Warsaw 1985.

    Google Scholar 

  14. Kokot, F., Więcek, A., Grzeszczak, W., Szczechowska, E., Dulawa, J.: The water immersion model in nephrology.Contrib. Nephrol., 70, 107 (1989).

    PubMed  CAS  Google Scholar 

  15. Kuczera, M., Kiersztejn, M., Kokot, F.: Endokrine Veränderungen bei Kranken mit aktiver Nierensteinkrankheit.Nieren-und Hochdruckkrankheiten, 22, 13 (1993).

    Google Scholar 

  16. Kuczera, M., Kiersztejn, M., Kokot, F.: Kalzitonin- und Glukagonsekretion bei aktiver Nephrolithiasis.Z. Gesamte Inn. Med., 42, 209 (1987).

    PubMed  CAS  Google Scholar 

  17. Maack, T., Park, C. H., Camargo, M.: Renal filtration, transport, and metabolism of hormones. In: Seldin, D. W., Giebisch, D. (eds). The Kidney: Physiology and Pathophysiology, Raven Press, New York 1985, p. 1773.

    Google Scholar 

  18. McMurray, J., Seidelin, P. H., Struthers, A. D.: Evidence for a proximal and distal nephron action of atrial natriuretic factor in man.Nephron, 51, 39 (1989).

    PubMed  CAS  Google Scholar 

  19. Michell, A. R.: Urolithiasis—historical, comparative and pathophysiological aspects: A review.J. R. Soc. Med., 82, 669 (1989).

    PubMed  CAS  Google Scholar 

  20. Morel, F.: Regulation of kidney functions by hormones: A new approach.Rec. Prog. Hormone Res., 39, 271 (1983).

    CAS  Google Scholar 

  21. Preminger, G. M.: The metabolic evaluation of patients with recurrent nephrolithiasis: A review of comprehensive and simplified approaches.J. Urol., 141, 760 (1989).

    PubMed  CAS  Google Scholar 

  22. Robertson, G. L.: Physiology of ADH secretion.Kidney Int., 32, Suppl. 21, 20 (1987).

    Google Scholar 

  23. Seymour, A. A., Blaine, E. H., Mazack, E. K., Smith, S. G., Stabilito, I. I., Haley, A. B., Napier, M. A., Whinnery, M. A., Nutt, R. F.: Renal and systemic effects of synthetic atrial natriuretic factor,Life Sci., 36, 33 (1985).

    Article  PubMed  CAS  Google Scholar 

  24. Smith, L. H.: Calcium-containing renal stones.Kidney Int., 13, 383 (1978).

    PubMed  CAS  Google Scholar 

  25. Takagi, T., Nishikawa, M., Mori, Y., Matsubara, H., Inada, M.: Effects of atrial natriuretic peptide infusion and its metabolism in patients with chronic renal failure.Endocrinol. Jpn., 38, 497 (1991).

    PubMed  CAS  Google Scholar 

  26. Weidmann, P., Hosler, L., Gnädinger, M. P., Lang, R. E., Uehlinger, D. E., Shaw, S., Rascher, W., Reubi, F. C.: Blood levels and renal effects of atrial natriuretic peptide in normal man.J. Clin. Invest., 77, 734 (1986).

    Article  PubMed  CAS  Google Scholar 

  27. Więcek, A.: Osmotyczna i nieosmotyczna regulacja wydzielania wazopresyny.Postępy Hig. Med. Dośw., 39, 195 (1985).

    PubMed  Google Scholar 

  28. Woolf, A. S., Lyon, T. L., Hoffbrand, B., Cohen, S., Moult, P.: The effects of physiological infusion of atrial natriuretic factor in normal subjects and patients with nephrotic syndrome.Nephron, 54, 244 (1989).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Silesian University School of Medicine, Katowicze, Poland

    F. Kokot, D. Klimek, A. Wi(ecek & M. Kuczera

Authors
  1. F. Kokot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Klimek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Wi(ecek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Kuczera
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kokot, F., Klimek, D., Wi(ecek, A. et al. Atrial natriuretic peptide and arginine-vasopressin secretion in patients with active renal stone disease. International Urology and Nephrology 30, 357–365 (1998). https://doi.org/10.1007/BF02550323

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550323

Keywords

Search

Navigation